• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P2Y13 受体激动剂效力的特征:一项荟萃分析。

Characterization of Potency of the P2Y13 Receptor Agonists: A Meta-Analysis.

机构信息

Department of Experimental Surgery, McGill University, Montreal, QC H3G 1A4, Canada.

Shriners Hospital for Children, Montreal, QC H4A 0A9, Canada.

出版信息

Int J Mol Sci. 2021 Mar 27;22(7):3468. doi: 10.3390/ijms22073468.

DOI:10.3390/ijms22073468
PMID:33801677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8036966/
Abstract

P2Y13 is an ADP-stimulated G-protein coupled receptor implicated in many physiological processes, including neurotransmission, metabolism, pain, and bone homeostasis. Quantitative understanding of P2Y13 activation dynamics is important for translational studies. We systematically identified PubMed annotated studies that characterized concentration-dependence of P2Y13 responses to natural and synthetic agonists. Since the comparison of the efficacy (maximum response) is difficult for studies performed in different systems, we normalized the data and conducted a meta-analysis of EC (concentration at half-maximum response) and Hill coefficient (slope) of P2Y13-mediated responses to different agonists. For signaling events induced by heterologously expressed P2Y13, EC of ADP-like agonists was 17.2 nM (95% CI: 7.7-38.5), with Hills coefficient of 4.4 (95% CI: 3.3-5.4), while ATP-like agonists had EC of 0.45 μM (95% CI: 0.06-3.15). For functional responses of endogenously expressed P2Y13, EC of ADP-like agonists was 1.76 μM (95% CI: 0.3-10.06). The EC of ADP-like agonists was lower for the brain P2Y13 than the blood P2Y13. ADP-like agonists were also more potent for human P2Y13 compared to rodent P2Y13. Thus, P2Y13 appears to be the most ADP-sensitive receptor characterized to date. The detailed understanding of tissue- and species-related differences in the P2Y13 response to ADP will improve the selectivity and specificity of future pharmacological compounds.

摘要

P2Y13 是一种 ADP 刺激的 G 蛋白偶联受体,参与许多生理过程,包括神经递质传递、代谢、疼痛和骨稳态。定量了解 P2Y13 的激活动力学对于转化研究很重要。我们系统地确定了 PubMed 注释研究,这些研究描述了 P2Y13 对天然和合成激动剂的浓度依赖性反应。由于比较不同系统中进行的研究的效价(最大反应)很困难,因此我们对数据进行了归一化,并对 P2Y13 介导的不同激动剂反应的 EC(半最大反应浓度)和 Hill 系数(斜率)进行了荟萃分析。对于异源表达的 P2Y13 诱导的信号事件,ADP 样激动剂的 EC 为 17.2 nM(95%CI:7.7-38.5),Hill 系数为 4.4(95%CI:3.3-5.4),而 ATP 样激动剂的 EC 为 0.45 μM(95%CI:0.06-3.15)。对于内源性表达的 P2Y13 的功能反应,ADP 样激动剂的 EC 为 1.76 μM(95%CI:0.3-10.06)。脑 P2Y13 的 ADP 样激动剂 EC 低于血液 P2Y13。与啮齿动物 P2Y13 相比,ADP 样激动剂对人 P2Y13 的作用更强。因此,P2Y13 似乎是迄今为止特征最明确的最敏感 ADP 的受体。详细了解 P2Y13 对 ADP 的反应在组织和物种之间的差异,将提高未来药理学化合物的选择性和特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/6ea4884c4bec/ijms-22-03468-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/6805ed22b370/ijms-22-03468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/614aa9a43021/ijms-22-03468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/ada0cfb13df0/ijms-22-03468-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/467ee6e62ada/ijms-22-03468-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/4fc96b100c37/ijms-22-03468-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/847a83ae3631/ijms-22-03468-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/1684f77a82dd/ijms-22-03468-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/6ea4884c4bec/ijms-22-03468-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/6805ed22b370/ijms-22-03468-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/614aa9a43021/ijms-22-03468-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/ada0cfb13df0/ijms-22-03468-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/467ee6e62ada/ijms-22-03468-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/4fc96b100c37/ijms-22-03468-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/847a83ae3631/ijms-22-03468-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/1684f77a82dd/ijms-22-03468-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf5/8036966/6ea4884c4bec/ijms-22-03468-g008.jpg

相似文献

1
Characterization of Potency of the P2Y13 Receptor Agonists: A Meta-Analysis.P2Y13 受体激动剂效力的特征:一项荟萃分析。
Int J Mol Sci. 2021 Mar 27;22(7):3468. doi: 10.3390/ijms22073468.
2
Nucleotide P2Y13-stimulated phosphorylation of CREB is required for ADP-induced proliferation of late developing retinal glial progenitors in culture.核苷酸P2Y13刺激的CREB磷酸化是培养中晚期发育的视网膜神经胶质祖细胞ADP诱导增殖所必需的。
Cell Signal. 2017 Jul;35:95-106. doi: 10.1016/j.cellsig.2017.03.019. Epub 2017 Mar 24.
3
IFN-stimulated P2Y13 protects mice from viral infection by suppressing the cAMP/EPAC1 signaling pathway.IFN 刺激的 P2Y13 通过抑制 cAMP/EPAC1 信号通路来保护小鼠免受病毒感染。
J Mol Cell Biol. 2019 May 1;11(5):395-407. doi: 10.1093/jmcb/mjy045.
4
Distinct P2Y Receptors Mediate Extension and Retraction of Microglial Processes in Epileptic and Peritumoral Human Tissue.不同的 P2Y 受体介导癫痫和肿瘤周围人类组织中小胶质细胞突起的延伸和回缩。
J Neurosci. 2020 Feb 12;40(7):1373-1388. doi: 10.1523/JNEUROSCI.0218-19.2019. Epub 2020 Jan 2.
5
Pharmacological characterization of the human P2Y13 receptor.人类P2Y13受体的药理学特性
Mol Pharmacol. 2003 Jul;64(1):104-12. doi: 10.1124/mol.64.1.104.
6
P2Y13 receptors mediate presynaptic inhibition of acetylcholine release induced by adenine nucleotides at the mouse neuromuscular junction.P2Y13受体介导腺嘌呤核苷酸在小鼠神经肌肉接头处诱导的乙酰胆碱释放的突触前抑制。
Neuroscience. 2016 Jun 21;326:31-44. doi: 10.1016/j.neuroscience.2016.03.066. Epub 2016 Apr 4.
7
Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation.腺苷酸环化酶 5 协调 ADP、P2Y1、P2Y13 和 ATP 门控 P2X7 受体在轴突伸长中的作用。
J Cell Sci. 2012 Jan 1;125(Pt 1):176-88. doi: 10.1242/jcs.091736. Epub 2012 Jan 16.
8
The role of purinergic P2Y and P2Y receptors in ADPβS-induced inhibition of the cardioaccelerator sympathetic drive in pithed rats.嘌呤能 P2Y 和 P2Y 受体在 ADPβS 诱导的麻醉大鼠心加速交感驱动抑制中的作用。
Purinergic Signal. 2020 Mar;16(1):73-84. doi: 10.1007/s11302-020-09689-z. Epub 2020 Feb 17.
9
Pharmacological and molecular characterization of functional P2 receptors in rat embryonic cardiomyocytes.大鼠胚胎心肌细胞中功能性P2受体的药理学和分子特征
Purinergic Signal. 2015 Mar;11(1):127-38. doi: 10.1007/s11302-014-9441-4. Epub 2014 Dec 16.
10
An Update on P2Y Receptor Signalling and Function.P2Y 受体信号转导与功能的最新研究进展。
Adv Exp Med Biol. 2017;1051:139-168. doi: 10.1007/5584_2017_91.

引用本文的文献

1
Pharmacological Profile of the Purinergic P2Y Receptors That Modulate, in Response to ADPβS, the Vasodepressor Sensory CGRPergic Outflow in Pithed Rats.嘌呤能P2Y受体的药理学特征,该受体响应ADPβS调节脊髓麻醉大鼠的血管减压性感觉降钙素基因相关肽能传出神经。
Pharmaceuticals (Basel). 2023 Mar 22;16(3):475. doi: 10.3390/ph16030475.
2
Purinergic P2 Receptors: Structure and Function 2.0.嘌呤能 P2 受体:结构与功能 2.0.
Int J Mol Sci. 2023 Mar 13;24(6):5462. doi: 10.3390/ijms24065462.
3
Migraine signaling pathways: purine metabolites that regulate migraine and predispose migraineurs to headache.

本文引用的文献

1
Update of P2Y receptor pharmacology: IUPHAR Review 27.P2Y受体药理学更新:IUPHAR综述27
Br J Pharmacol. 2020 Jun;177(11):2413-2433. doi: 10.1111/bph.15005. Epub 2020 Apr 6.
2
Introduction to Purinergic Signalling in the Brain.脑内嘌呤能信号转导导论。
Adv Exp Med Biol. 2020;1202:1-12. doi: 10.1007/978-3-030-30651-9_1.
3
Distinct P2Y Receptors Mediate Extension and Retraction of Microglial Processes in Epileptic and Peritumoral Human Tissue.不同的 P2Y 受体介导癫痫和肿瘤周围人类组织中小胶质细胞突起的延伸和回缩。
偏头痛信号通路:嘌呤代谢物调节偏头痛并使偏头痛患者易患头痛。
Mol Cell Biochem. 2023 Dec;478(12):2813-2848. doi: 10.1007/s11010-023-04701-7. Epub 2023 Mar 22.
4
Extracellular ATP and its derivatives provide spatiotemporal guidance for bone adaptation to wide spectrum of physical forces.细胞外ATP及其衍生物为骨骼适应广泛的物理力提供时空引导。
Bone Rep. 2022 Aug 1;17:101608. doi: 10.1016/j.bonr.2022.101608. eCollection 2022 Dec.
5
Exploring the Therapeutic Potential of Targeting Purinergic and Orexinergic Receptors in Alcoholic Neuropathy.探索靶向嘌呤能和食欲素能受体在酒精性神经病变中的治疗潜力。
Neurotox Res. 2022 Apr;40(2):646-669. doi: 10.1007/s12640-022-00477-8. Epub 2022 Jan 26.
J Neurosci. 2020 Feb 12;40(7):1373-1388. doi: 10.1523/JNEUROSCI.0218-19.2019. Epub 2020 Jan 2.
4
Transmission of Mechanical Information by Purinergic Signaling.嘌呤能信号传递机械信息。
Biophys J. 2019 May 21;116(10):2009-2022. doi: 10.1016/j.bpj.2019.04.012. Epub 2019 Apr 22.
5
Meta-Analytic Methodology for Basic Research: A Practical Guide.基础研究的元分析方法:实用指南。
Front Physiol. 2019 Mar 27;10:203. doi: 10.3389/fphys.2019.00203. eCollection 2019.
6
Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y receptor.解析坎格雷洛和替格瑞洛在 P2Y 受体上的偏向性反向激动作用。
Cell Mol Life Sci. 2019 Feb;76(3):561-576. doi: 10.1007/s00018-018-2960-3. Epub 2018 Nov 7.
7
IFN-stimulated P2Y13 protects mice from viral infection by suppressing the cAMP/EPAC1 signaling pathway.IFN 刺激的 P2Y13 通过抑制 cAMP/EPAC1 信号通路来保护小鼠免受病毒感染。
J Mol Cell Biol. 2019 May 1;11(5):395-407. doi: 10.1093/jmcb/mjy045.
8
Microglia P2Y Receptors Prevent Astrocyte Proliferation Mediated by P2Y Receptors.小胶质细胞P2Y受体可阻止由P2Y受体介导的星形胶质细胞增殖。
Front Pharmacol. 2018 May 3;9:418. doi: 10.3389/fphar.2018.00418. eCollection 2018.
9
An Update on P2Y Receptor Signalling and Function.P2Y 受体信号转导与功能的最新研究进展。
Adv Exp Med Biol. 2017;1051:139-168. doi: 10.1007/5584_2017_91.
10
Nucleotide P2Y13-stimulated phosphorylation of CREB is required for ADP-induced proliferation of late developing retinal glial progenitors in culture.核苷酸P2Y13刺激的CREB磷酸化是培养中晚期发育的视网膜神经胶质祖细胞ADP诱导增殖所必需的。
Cell Signal. 2017 Jul;35:95-106. doi: 10.1016/j.cellsig.2017.03.019. Epub 2017 Mar 24.